Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Marqibo (vincristine liposomal)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Aurobindo, CASI, Servier

Drug class:

Tubulin polymerization inhibitor

Related drugs:

No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	vincristine liposomal Sensitive: A1 - Approval vincristine liposomal Sensitive : A1	vincristine liposomal Sensitive: A1 - Approval vincristine liposomal Sensitive : A1
No biomarker	Astrocytoma	No biomarker	Astrocytoma	lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive: A2 - Guideline lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive : A2	lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive: A2 - Guideline lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive : A2
No biomarker	B Acute Lymphoblastic Leukemia	No biomarker	B Acute Lymphoblastic Leukemia	vincristine liposomal Sensitive: A2 - Guideline vincristine liposomal Sensitive : A2	vincristine liposomal Sensitive: A2 - Guideline vincristine liposomal Sensitive : A2